Primary Prevention of Stroke in Children With Sickle Cell Disease in Sub-Saharan Africa II
Phase of Trial: Phase III
Latest Information Update: 24 Mar 2017
At a glance
- Drugs Hydroxycarbamide (Primary)
- Indications Stroke
- Focus Therapeutic Use
- Acronyms SPRING
- 21 Jul 2016 Planned number of patients changed from 220 to 440.
- 21 Jul 2016 Status changed from not yet recruiting to recruiting.
- 02 Dec 2015 Planned initiation date changed from 1 Sep 2015 to 1 Jan 2016, according to ClinicalTrials.gov record.